Cost and Health Care Resource Utilization Differences After Spine Surgery for Bony Spine versus Primary Intradural Spine Tumors.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
07 2021
Historique:
received: 17 03 2021
accepted: 06 04 2021
pubmed: 19 4 2021
medline: 15 9 2021
entrez: 18 4 2021
Statut: ppublish

Résumé

The aim of this study was to compare complication rates, length of stay (LOS), and hospital costs after spine surgery for bony spine tumors and intradural spinal neoplasms. A retrospective cohort study was performed using the National Inpatient Sample database from 2016 to 2017. All adult inpatients who underwent surgical intervention for a primary intradural spinal tumor or primary/metastatic bony spine tumor were identified using International Classification of Diseases, Tenth Revision, Clinical Modification diagnosis/procedural coding systems. Patient demographics, comorbidities, intraoperative variables, complications, LOS, discharge disposition, and total cost of hospitalization were assessed. Backward stepwise multivariable logistic regression analyses were used to identify independent predictors of perioperative complication, extended LOS (≥75th percentile), and increased cost (≥75th percentile). A total of 9855 adult patients were included in the study; 3850 (39.1%) were identified as having a primary intradural spinal tumor and 6005 (60.9%) had a primary or metastatic bony spine tumor. Those treated for bony tumors had more comorbidities (≥3, 67.8% vs. 29.2%) and more commonly experienced ≥1 complications (29.9% vs. 7.9%). Multivariate analyses also showed those in the bony spine cohort had a higher odds of experiencing ≥1 complications (odds ratio [OR], 4.26; 95% confidence interval [CI], 3.04-5.97; P < 0.001), extended LOS (OR, 2.44; 95% CI, 1.75-3.38; P < 0.001), and increased cost (OR, 5.32; 95% CI, 3.67-7.71; P < 0.001). Relative to patients being treated for primary intradural tumors, those undergoing spine surgery for bony spine tumors experience significantly higher risk for perioperative complications, extended LOS, and increased cost of hospital admission. Further identification of patient and treatment characteristics that may optimize management of spine oncology may reduce adverse outcomes, improve patient care, and reduce health care resources.

Identifiants

pubmed: 33866030
pii: S1878-8750(21)00555-6
doi: 10.1016/j.wneu.2021.04.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e286-e298

Informations de copyright

Published by Elsevier Inc.

Auteurs

Aladine A Elsamadicy (AA)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address: aladine.elsamadicy@yale.edu.

Andrew B Koo (AB)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.

Benjamin C Reeves (BC)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.

Isaac G Freedman (IG)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.

Zach Pennington (Z)

Department of Neurosurgery, John Hopkins School of Medicine, Baltimore, Maryland, USA.

Wyatt B David (WB)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.

Jeff Ehresman (J)

Department of Neurosurgery, John Hopkins School of Medicine, Baltimore, Maryland, USA.

Astrid Hengartner (A)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.

Maxwell Laurans (M)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.

Luis Kolb (L)

Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.

John H Shin (JH)

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Daniel M Sciubba (DM)

Department of Neurosurgery, John Hopkins School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH